600227.SS Stock - Guizhou Chitianhua Co., Ltd. Class A
Unlock GoAI Insights for 600227.SS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.38B | $2.25B | $2.52B | $2.18B | $1.93B |
| Gross Profit | $229.20M | $177.30M | $145.57M | $421.68M | $604.44M |
| Gross Margin | 9.6% | 7.9% | 5.8% | 19.3% | 31.4% |
| Operating Income | $-76,789,477 | $-132,419,086 | $-172,866,084.86 | $56.75M | $200.19M |
| Net Income | $-86,693,483 | $-119,274,849 | $-371,483,499.53 | $-56,643,806.37 | $55.61M |
| Net Margin | -3.6% | -5.3% | -14.8% | -2.6% | 2.9% |
| EPS | $-0.05 | $-0.07 | $-0.22 | $-0.03 | $0.03 |
Guizhou Chitianhua Co.,Ltd. engages in the chemical and pharmaceutical businesses in China. The company offers urea fertilizers; synthetic ammonia and ammonium sulfate; and sulfuric acid, industrial nitrogen, industrial ammonia, and industrial hydrogen, as well as basic chemical products and their deep-processed and by-products. It also produces and sells pharmaceuticals; medical equipment; and drugs for diabetes, cardiovascular, dermatology, gynecological, digestive system, endocrine, and psychotropic diseases. In addition, the company engages in the production of Chinese and western patent medicines; class II clinical laboratory analysis instruments; and sanitary products, as well as sales of self-produced products. Further, it is involved in the manufacture and sales of special and daily chemical products; provision of technical development, consultation, exchanges, and services; technology transfer and promotion; coal washing; sales of coal products; import and export of technology and goods; motor vehicle repair and maintenance; health care products; retailing of prepackaged foods; software technology development and services; data processing services; health consultation; production and sales of cosmetics; planting of Chinese herbal medicines; sales and storage services of cells; research on stem cell biotechnology and gene technology; production of biological products; investment in coal construction projects; and sales of industrial and mining products, mining equipment and spare parts. The company was formerly known as Guizhou Salvage Pharmaceutical Co.,Ltd. and changed its name to Guizhou Chitianhua Co.,Ltd. in May 2023. Guizhou Chitianhua Co.,Ltd. was founded in 1998 and is based in Guiyang, China.
Visit WebsiteEarnings History & Surprises
600227.SSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.06 | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 16, 2025 | — | $-0.03 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.03 | — | — |
Q3 2024 | Sep 30, 2024 | — | $0.00 | — | — |
Q2 2024 | Jun 30, 2024 | — | $0.00 | — | — |
Q2 2024 | Apr 10, 2024 | — | $-0.02 | — | — |
Q1 2024 | Jan 31, 2024 | — | $-0.05 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.07 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.07 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.09 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.08 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 28, 2022 | — | $-0.10 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.05 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.03 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about 600227.SS
What is 600227.SS's current stock price?
What is the analyst price target for 600227.SS?
What sector is Guizhou Chitianhua Co., Ltd. Class A in?
What is 600227.SS's market cap?
Does 600227.SS pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to 600227.SS for comparison